Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest Articles15-Deoxy-delta12,14-prostaglandin J2 Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells
Therapeutic Apheresis and Dialysis, 07/30/09
Yokoyama Y et al. – The findings suggest that 15d–PGJ2 has a novel and potent antifibrotic effect in HPMC and this action is likely mediated by HGF.
Related Articles
Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?
Journal of the American Board of Family Medicine, 11/09/09
Relevance Score: 91%
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
Stroke, 11/10/09
Relevance Score: 89%
Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia
Acta Neurologica Belgica, 10/20/09
Relevance Score: 89%
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
Annals of Internal Medicine, 10/20/09
Relevance Score: 87%
Sodium Load Combined with Low Doses of Exogenous Angiotensin II Upregulate Intrarenal Angiotensin II
Kidney and Blood Pressure Research, 10/08/09
Relevance Score: 87%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury
Kidney International, 12/03/09
Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
Nephron: Experimental Nephrology, 12/02/09
A family with X-linked benign familial hematuria
Pediatric Nephrology, 12/01/09
Article Search
Sponsor